Boston An independent LDT provider

Thomas King


Dr. Thomas King is a board-certified pathologist with a PhD in molecular biology. He has extensive experience as a laboratory director in hospital, academic, and corporate settings.
Dr. King received his MD and PhD degrees from Washington University in 1984 through the NIH-funded Medical Scientist Training Program (MSTP). After completing residency in anatomic pathology at Washington University Medical Center in 1987, Dr. King moved on to become an Associate Professor of Pathology at Brown University, where he was also Pathology Residency Program Director and acting Chief of Pathology. He was subsequently Senior Director of Molecular Pathology at Millennium Pharmaceuticals and an Associate Professor at Boston University School of Medicine. Dr. King is currently the Medical Director of Immunovia, Inc., in Marlborough, Massachusetts, employing proteomic biomarkers as diagnostic tools.

Current assignments: Adjunct Associate Professor, School of Health Professions, Rutgers, The State University Of New Jersey, Newark, NJ; and Director, Medpace Holdings, Inc. (Medp, Nasdaq)